Sebt Vala, Sharifi Shahnaz, Meysamie Alipasha, Saberi Kianoush
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Critical Care Quality Improvement Research Center, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ann Card Anaesth. 2025 Apr 1;28(2):136-142. doi: 10.4103/aca.aca_192_24. Epub 2025 Apr 16.
Bleeding represents a major complication in heart surgeries. However, even small amounts of allogeneic blood are associated with reduced long-term survival and short-term complications. Acute normovolemic hemodilution (ANH) serves as a viable alternative, but its effectiveness and safety remain controversial.
We aimed to clarify the effects of mild-volume ANH on blood transfusions and short-term complications following heart surgeries.
This was a quasi-experimental study in a referral center on 2271 patients. We performed an extensive propensity-score matching to mitigate the lack of random assignment and potential selection bias. This resulted in 778 patients with no significant differences in 28 variables, including clinical, paraclinical, and operative features.
ANH significantly reduced the rate of RBC transfusion by 16% (50.9% vs. 60.9%; RR: 0.84; P = 0.006) and the number of transfused RBCs by 0.24 units (0.96 ± 1.32 vs. 1.20 ± 1.39; P = 0.013) but did not affect the transfusion of FFP or platelets. Furthermore, ANH significantly lowered the incidence of lactic acidosis by 53% (6.8 vs. 11.3%; RR: 0.47; P < 0.001) but had no notable impact on other short-term outcomes following heart surgery, including mortality, re-intubation, re-exploration, delayed sternal closure, length of ICU stay, or duration of mechanical ventilation.
Mild-volume ANH significantly reduced the rate and amount of perioperative RBC transfusions, as well as the incidence of lactic acidosis following heart surgery. ANH did not affect the incidence of other complications during hospitalization.
This suggests that ANH could be a safe and beneficial blood conservation technique. Further randomized clinical trials are needed to evaluate its effects.
出血是心脏手术中的主要并发症。然而,即使少量的异体血也与长期生存率降低和短期并发症相关。急性等容血液稀释(ANH)是一种可行的替代方法,但其有效性和安全性仍存在争议。
我们旨在阐明轻度容量ANH对心脏手术后输血和短期并发症的影响。
这是一项在转诊中心对2271例患者进行的准实验研究。我们进行了广泛的倾向评分匹配,以减轻缺乏随机分配和潜在选择偏倚的影响。这产生了778例患者,他们在28个变量上没有显著差异,包括临床、辅助检查和手术特征。
ANH显著降低了红细胞输注率16%(50.9%对60.9%;RR:0.84;P = 0.006),并使输注的红细胞数量减少了0.24单位(0.96±1.32对1.20±1.39;P = 0.013),但不影响新鲜冰冻血浆或血小板的输注。此外,ANH显著降低了乳酸酸中毒的发生率53%(6.8对11.3%;RR:0.47;P < 0.001),但对心脏手术后的其他短期结局没有显著影响,包括死亡率、再次插管、再次探查、延迟胸骨闭合、重症监护病房住院时间或机械通气时间。
轻度容量ANH显著降低了心脏手术后围手术期红细胞输注率和输注量,以及乳酸酸中毒的发生率。ANH不影响住院期间其他并发症的发生率。
这表明ANH可能是一种安全有益的血液保护技术。需要进一步的随机临床试验来评估其效果。